nodes	percent_of_prediction	percent_of_DWPC	metapath
Porfimer—Photosensitizing Activity—Methoxsalen—hematologic cancer	0.444	0.5	CiPCiCtD
Porfimer—Photoabsorption—Methoxsalen—hematologic cancer	0.444	0.5	CiPCiCtD
Porfimer—FCGR1A—testis—hematologic cancer	0.00542	0.21	CbGeAlD
Porfimer—LDLR—hematopoietic system—hematologic cancer	0.00445	0.172	CbGeAlD
Porfimer—LDLR—gonad—hematologic cancer	0.00338	0.131	CbGeAlD
Porfimer—LDLR—blood—hematologic cancer	0.00295	0.114	CbGeAlD
Porfimer—LDLR—bone marrow—hematologic cancer	0.00285	0.11	CbGeAlD
Porfimer—LDLR—lung—hematologic cancer	0.00258	0.1	CbGeAlD
Porfimer—LDLR—testis—hematologic cancer	0.00244	0.0943	CbGeAlD
Porfimer—LDLR—lymph node—hematologic cancer	0.00177	0.0684	CbGeAlD
Porfimer—LDLR—Signaling Pathways—PTHLH—hematologic cancer	2.67e-05	0.000308	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SDC1—hematologic cancer	2.67e-05	0.000308	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PIK3R1—hematologic cancer	2.66e-05	0.000308	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.66e-05	0.000307	CbGpPWpGaD
Porfimer—LDLR—Disease—STAT5A—hematologic cancer	2.64e-05	0.000305	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN2B—hematologic cancer	2.62e-05	0.000303	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PTGER4—hematologic cancer	2.6e-05	0.0003	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—FGF2—hematologic cancer	2.59e-05	0.0003	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—JAK2—hematologic cancer	2.59e-05	0.000299	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—LCK—hematologic cancer	2.58e-05	0.000299	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CYCS—hematologic cancer	2.57e-05	0.000297	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD86—hematologic cancer	2.57e-05	0.000297	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—BCL2—hematologic cancer	2.56e-05	0.000296	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—PIK3R1—hematologic cancer	2.56e-05	0.000296	CbGpPWpGaD
Porfimer—LDLR—Metabolism—HSP90AA1—hematologic cancer	2.55e-05	0.000295	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—H3F3A—hematologic cancer	2.53e-05	0.000293	CbGpPWpGaD
Porfimer—LDLR—Disease—CD86—hematologic cancer	2.53e-05	0.000293	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MDM2—hematologic cancer	2.53e-05	0.000292	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD40LG—hematologic cancer	2.52e-05	0.000291	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—HGF—hematologic cancer	2.52e-05	0.000291	CbGpPWpGaD
Porfimer—LDLR—Disease—HES1—hematologic cancer	2.5e-05	0.000289	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD8A—hematologic cancer	2.49e-05	0.000288	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CSF2—hematologic cancer	2.49e-05	0.000288	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FGF1—hematologic cancer	2.49e-05	0.000288	CbGpPWpGaD
Porfimer—LDLR—Disease—NCOR1—hematologic cancer	2.48e-05	0.000287	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—HRAS—hematologic cancer	2.47e-05	0.000286	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PRKCZ—hematologic cancer	2.46e-05	0.000285	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PIK3CB—hematologic cancer	2.46e-05	0.000284	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MTOR—hematologic cancer	2.46e-05	0.000284	CbGpPWpGaD
Porfimer—LDLR—Disease—FGF1—hematologic cancer	2.46e-05	0.000284	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CD4—hematologic cancer	2.45e-05	0.000284	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FOXO1—hematologic cancer	2.45e-05	0.000283	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PDGFRB—hematologic cancer	2.45e-05	0.000283	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—MDM2—hematologic cancer	2.43e-05	0.00028	CbGpPWpGaD
Porfimer—LDLR—Disease—FOXO1—hematologic cancer	2.42e-05	0.00028	CbGpPWpGaD
Porfimer—LDLR—Disease—PDGFRB—hematologic cancer	2.42e-05	0.000279	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PDGFRA—hematologic cancer	2.41e-05	0.000278	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—JAK1—hematologic cancer	2.4e-05	0.000278	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PRKCG—hematologic cancer	2.4e-05	0.000278	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—HLA-B—hematologic cancer	2.39e-05	0.000277	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PARP1—hematologic cancer	2.38e-05	0.000275	CbGpPWpGaD
Porfimer—LDLR—Disease—PDGFRA—hematologic cancer	2.38e-05	0.000275	CbGpPWpGaD
Porfimer—LDLR—Disease—JAK1—hematologic cancer	2.37e-05	0.000274	CbGpPWpGaD
Porfimer—LDLR—Disease—PRKCG—hematologic cancer	2.37e-05	0.000274	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—IL6—hematologic cancer	2.37e-05	0.000273	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—MTOR—hematologic cancer	2.36e-05	0.000273	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—PIK3CB—hematologic cancer	2.36e-05	0.000273	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CD4—hematologic cancer	2.36e-05	0.000272	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FBXW7—hematologic cancer	2.34e-05	0.00027	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CDKN1B—hematologic cancer	2.31e-05	0.000267	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.3e-05	0.000265	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HDAC2—hematologic cancer	2.29e-05	0.000265	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CXCR4—hematologic cancer	2.29e-05	0.000265	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GSTP1—hematologic cancer	2.26e-05	0.000262	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL2RA—hematologic cancer	2.24e-05	0.000259	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CBL—hematologic cancer	2.24e-05	0.000258	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—HLA-A—hematologic cancer	2.22e-05	0.000256	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CDKN1B—hematologic cancer	2.21e-05	0.000256	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL3—hematologic cancer	2.21e-05	0.000256	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—JUN—hematologic cancer	2.2e-05	0.000254	CbGpPWpGaD
Porfimer—LDLR—Disease—MTHFR—hematologic cancer	2.19e-05	0.000254	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.19e-05	0.000253	CbGpPWpGaD
Porfimer—LDLR—Disease—TERT—hematologic cancer	2.19e-05	0.000253	CbGpPWpGaD
Porfimer—LDLR—Disease—HLA-A—hematologic cancer	2.19e-05	0.000253	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PTPN1—hematologic cancer	2.18e-05	0.000251	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PDGFB—hematologic cancer	2.16e-05	0.00025	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ABCB1—hematologic cancer	2.14e-05	0.000248	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—RASGRP1—hematologic cancer	2.14e-05	0.000247	CbGpPWpGaD
Porfimer—LDLR—Disease—PDGFB—hematologic cancer	2.14e-05	0.000247	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HSP90AA1—hematologic cancer	2.13e-05	0.000247	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SYK—hematologic cancer	2.13e-05	0.000247	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CDKN1A—hematologic cancer	2.13e-05	0.000246	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—BCL2L1—hematologic cancer	2.13e-05	0.000246	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PTEN—hematologic cancer	2.12e-05	0.000245	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CRP—hematologic cancer	2.12e-05	0.000244	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—TSC2—hematologic cancer	2.12e-05	0.000244	CbGpPWpGaD
Porfimer—LDLR—Disease—TSC2—hematologic cancer	2.09e-05	0.000241	CbGpPWpGaD
Porfimer—LDLR—Metabolism—NCOR1—hematologic cancer	2.08e-05	0.00024	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GSTM1—hematologic cancer	2.08e-05	0.00024	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MAPK8—hematologic cancer	2.08e-05	0.00024	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—STAT1—hematologic cancer	2.06e-05	0.000238	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CDKN1A—hematologic cancer	2.04e-05	0.000236	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—PTEN—hematologic cancer	2.04e-05	0.000236	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FGFR3—hematologic cancer	2.03e-05	0.000235	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—EP300—hematologic cancer	2.03e-05	0.000234	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAPK14—hematologic cancer	2.01e-05	0.000233	CbGpPWpGaD
Porfimer—LDLR—Disease—FGFR3—hematologic cancer	2.01e-05	0.000232	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—SRC—hematologic cancer	1.97e-05	0.000228	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—ICAM1—hematologic cancer	1.94e-05	0.000225	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—NFKBIA—hematologic cancer	1.93e-05	0.000223	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—BAD—hematologic cancer	1.93e-05	0.000223	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—GRB2—hematologic cancer	1.92e-05	0.000222	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PDGFA—hematologic cancer	1.92e-05	0.000222	CbGpPWpGaD
Porfimer—LDLR—Disease—BAD—hematologic cancer	1.9e-05	0.00022	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—NRAS—hematologic cancer	1.89e-05	0.000219	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—KITLG—hematologic cancer	1.89e-05	0.000219	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—SRC—hematologic cancer	1.89e-05	0.000219	CbGpPWpGaD
Porfimer—LDLR—Disease—NOTCH1—hematologic cancer	1.89e-05	0.000218	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD80—hematologic cancer	1.87e-05	0.000216	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—KIT—hematologic cancer	1.87e-05	0.000216	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—STAT5A—hematologic cancer	1.85e-05	0.000214	CbGpPWpGaD
Porfimer—LDLR—Disease—CD80—hematologic cancer	1.85e-05	0.000214	CbGpPWpGaD
Porfimer—LDLR—Disease—KIT—hematologic cancer	1.84e-05	0.000213	CbGpPWpGaD
Porfimer—LDLR—Metabolism—MTHFR—hematologic cancer	1.84e-05	0.000212	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PTPN11—hematologic cancer	1.84e-05	0.000212	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN2B—hematologic cancer	1.83e-05	0.000212	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—NRAS—hematologic cancer	1.82e-05	0.00021	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MAPK3—hematologic cancer	1.81e-05	0.00021	CbGpPWpGaD
Porfimer—LDLR—Disease—PTPN11—hematologic cancer	1.81e-05	0.000209	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FOS—hematologic cancer	1.78e-05	0.000206	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CREB1—hematologic cancer	1.78e-05	0.000206	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CD86—hematologic cancer	1.77e-05	0.000205	CbGpPWpGaD
Porfimer—LDLR—Disease—CREB1—hematologic cancer	1.76e-05	0.000203	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HES1—hematologic cancer	1.75e-05	0.000202	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CASP8—hematologic cancer	1.74e-05	0.000201	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NCOR1—hematologic cancer	1.74e-05	0.000201	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL6R—hematologic cancer	1.73e-05	0.0002	CbGpPWpGaD
Porfimer—LDLR—Disease—BRAF—hematologic cancer	1.73e-05	0.0002	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CREBBP—hematologic cancer	1.73e-05	0.0002	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FGF1—hematologic cancer	1.72e-05	0.000199	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CSF2—hematologic cancer	1.72e-05	0.000199	CbGpPWpGaD
Porfimer—LDLR—Disease—IL6R—hematologic cancer	1.71e-05	0.000198	CbGpPWpGaD
Porfimer—LDLR—Disease—CREBBP—hematologic cancer	1.71e-05	0.000198	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FOXO1—hematologic cancer	1.69e-05	0.000196	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PDGFRB—hematologic cancer	1.69e-05	0.000196	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PDGFRA—hematologic cancer	1.67e-05	0.000192	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—JAK1—hematologic cancer	1.66e-05	0.000192	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PRKCG—hematologic cancer	1.66e-05	0.000192	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAP2K1—hematologic cancer	1.65e-05	0.000191	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PIK3CD—hematologic cancer	1.64e-05	0.00019	CbGpPWpGaD
Porfimer—LDLR—Disease—MAP2K1—hematologic cancer	1.63e-05	0.000189	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—KRAS—hematologic cancer	1.63e-05	0.000188	CbGpPWpGaD
Porfimer—LDLR—Disease—PIK3CD—hematologic cancer	1.62e-05	0.000187	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.62e-05	0.000187	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FGF2—hematologic cancer	1.57e-05	0.000182	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—KRAS—hematologic cancer	1.57e-05	0.000181	CbGpPWpGaD
Porfimer—LDLR—Disease—FGF2—hematologic cancer	1.55e-05	0.000179	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PIK3R1—hematologic cancer	1.55e-05	0.000179	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL2RA—hematologic cancer	1.55e-05	0.000179	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3CG—hematologic cancer	1.54e-05	0.000178	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TERT—hematologic cancer	1.53e-05	0.000177	CbGpPWpGaD
Porfimer—LDLR—Disease—PIK3R1—hematologic cancer	1.53e-05	0.000177	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—JAK2—hematologic cancer	1.51e-05	0.000174	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PIK3CA—hematologic cancer	1.5e-05	0.000173	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PDGFB—hematologic cancer	1.5e-05	0.000173	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—BCL2—hematologic cancer	1.49e-05	0.000173	CbGpPWpGaD
Porfimer—LDLR—Disease—JAK2—hematologic cancer	1.49e-05	0.000172	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IFNG—hematologic cancer	1.48e-05	0.000171	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MDM2—hematologic cancer	1.47e-05	0.00017	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TSC2—hematologic cancer	1.46e-05	0.000169	CbGpPWpGaD
Porfimer—LDLR—Disease—MDM2—hematologic cancer	1.45e-05	0.000168	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—PIK3CA—hematologic cancer	1.44e-05	0.000166	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CREBBP—hematologic cancer	1.43e-05	0.000165	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PIK3CB—hematologic cancer	1.43e-05	0.000165	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MTOR—hematologic cancer	1.43e-05	0.000165	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD4—hematologic cancer	1.43e-05	0.000165	CbGpPWpGaD
Porfimer—LDLR—Disease—PIK3CB—hematologic cancer	1.41e-05	0.000163	CbGpPWpGaD
Porfimer—LDLR—Disease—MTOR—hematologic cancer	1.41e-05	0.000163	CbGpPWpGaD
Porfimer—LDLR—Disease—CD4—hematologic cancer	1.41e-05	0.000163	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FGFR3—hematologic cancer	1.41e-05	0.000163	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAPK14—hematologic cancer	1.39e-05	0.000161	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—HRAS—hematologic cancer	1.39e-05	0.00016	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—ESR1—hematologic cancer	1.37e-05	0.000158	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3CD—hematologic cancer	1.36e-05	0.000157	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FN1—hematologic cancer	1.35e-05	0.000156	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CDKN1B—hematologic cancer	1.34e-05	0.000155	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ALB—hematologic cancer	1.34e-05	0.000155	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—BAD—hematologic cancer	1.33e-05	0.000154	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NFKBIA—hematologic cancer	1.33e-05	0.000154	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—HRAS—hematologic cancer	1.33e-05	0.000154	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—IL6—hematologic cancer	1.33e-05	0.000153	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN1B—hematologic cancer	1.33e-05	0.000153	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NOTCH1—hematologic cancer	1.32e-05	0.000153	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL1B—hematologic cancer	1.32e-05	0.000153	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL2—hematologic cancer	1.31e-05	0.000152	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CD80—hematologic cancer	1.29e-05	0.00015	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3CG—hematologic cancer	1.29e-05	0.000149	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—KIT—hematologic cancer	1.29e-05	0.000149	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3R1—hematologic cancer	1.28e-05	0.000148	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—JUN—hematologic cancer	1.28e-05	0.000148	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PTPN11—hematologic cancer	1.27e-05	0.000147	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CDKN1A—hematologic cancer	1.24e-05	0.000143	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PTEN—hematologic cancer	1.24e-05	0.000143	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CREB1—hematologic cancer	1.23e-05	0.000142	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—AKT1—hematologic cancer	1.22e-05	0.000141	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN1A—hematologic cancer	1.22e-05	0.000141	CbGpPWpGaD
Porfimer—LDLR—Disease—PTEN—hematologic cancer	1.22e-05	0.000141	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—BRAF—hematologic cancer	1.21e-05	0.00014	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAPK8—hematologic cancer	1.21e-05	0.00014	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCL2—hematologic cancer	1.2e-05	0.000139	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL6R—hematologic cancer	1.2e-05	0.000139	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CREBBP—hematologic cancer	1.2e-05	0.000138	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3CB—hematologic cancer	1.18e-05	0.000137	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—EP300—hematologic cancer	1.18e-05	0.000136	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—AKT1—hematologic cancer	1.18e-05	0.000136	CbGpPWpGaD
Porfimer—LDLR—Disease—EP300—hematologic cancer	1.16e-05	0.000135	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—SRC—hematologic cancer	1.15e-05	0.000133	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAP2K1—hematologic cancer	1.14e-05	0.000132	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3CD—hematologic cancer	1.14e-05	0.000131	CbGpPWpGaD
Porfimer—LDLR—Disease—SRC—hematologic cancer	1.13e-05	0.000131	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—STAT3—hematologic cancer	1.11e-05	0.000128	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—NRAS—hematologic cancer	1.1e-05	0.000128	CbGpPWpGaD
Porfimer—LDLR—Disease—STAT3—hematologic cancer	1.09e-05	0.000126	CbGpPWpGaD
Porfimer—LDLR—Disease—NRAS—hematologic cancer	1.09e-05	0.000126	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—FGF2—hematologic cancer	1.09e-05	0.000126	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3R1—hematologic cancer	1.07e-05	0.000124	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAPK3—hematologic cancer	1.06e-05	0.000122	CbGpPWpGaD
Porfimer—LDLR—Disease—MAPK3—hematologic cancer	1.04e-05	0.000121	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—JAK2—hematologic cancer	1.04e-05	0.00012	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PTEN—hematologic cancer	1.02e-05	0.000118	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MDM2—hematologic cancer	1.02e-05	0.000118	CbGpPWpGaD
Porfimer—LDLR—Disease—MYC—hematologic cancer	1.01e-05	0.000117	CbGpPWpGaD
Porfimer—LDLR—Disease—TGFB1—hematologic cancer	1.01e-05	0.000117	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3CB—hematologic cancer	9.89e-06	0.000114	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MTOR—hematologic cancer	9.89e-06	0.000114	CbGpPWpGaD
Porfimer—LDLR—Metabolism—EP300—hematologic cancer	9.75e-06	0.000113	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—KRAS—hematologic cancer	9.5e-06	0.00011	CbGpPWpGaD
Porfimer—LDLR—Disease—KRAS—hematologic cancer	9.37e-06	0.000108	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN1B—hematologic cancer	9.28e-06	0.000107	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CASP3—hematologic cancer	9.1e-06	0.000105	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL2—hematologic cancer	9.09e-06	0.000105	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCND1—hematologic cancer	8.86e-06	0.000102	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—JUN—hematologic cancer	8.84e-06	0.000102	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PIK3CA—hematologic cancer	8.73e-06	0.000101	CbGpPWpGaD
Porfimer—LDLR—Disease—PIK3CA—hematologic cancer	8.61e-06	9.96e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN1A—hematologic cancer	8.57e-06	9.9e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PTEN—hematologic cancer	8.55e-06	9.88e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAPK8—hematologic cancer	8.36e-06	9.67e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—EP300—hematologic cancer	8.15e-06	9.42e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—HRAS—hematologic cancer	8.07e-06	9.33e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—HRAS—hematologic cancer	7.97e-06	9.21e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SRC—hematologic cancer	7.93e-06	9.16e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL6—hematologic cancer	7.73e-06	8.93e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—VEGFA—hematologic cancer	7.72e-06	8.93e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—STAT3—hematologic cancer	7.65e-06	8.84e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NRAS—hematologic cancer	7.63e-06	8.82e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—IL6—hematologic cancer	7.63e-06	8.82e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAPK3—hematologic cancer	7.3e-06	8.44e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3CA—hematologic cancer	7.21e-06	8.34e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—AKT1—hematologic cancer	7.13e-06	8.24e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MYC—hematologic cancer	7.1e-06	8.21e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TGFB1—hematologic cancer	7.09e-06	8.19e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—AKT1—hematologic cancer	7.04e-06	8.13e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—KRAS—hematologic cancer	6.56e-06	7.59e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3CA—hematologic cancer	6.03e-06	6.97e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—AKT1—hematologic cancer	5.89e-06	6.81e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TP53—hematologic cancer	5.83e-06	6.74e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HRAS—hematologic cancer	5.58e-06	6.45e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL6—hematologic cancer	5.34e-06	6.17e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—AKT1—hematologic cancer	4.93e-06	5.7e-05	CbGpPWpGaD
